Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

NCT00003338 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma

Interventions

PROCEDURE: immunoscintigraphy
RADIATION: technetium Tc 99m epratuzumab

Sponsor

Gilead Sciences